BMJ  2007;334 (10 February), doi:10.1136/bmj.39120.563542.3A

Editor's Choice

US editor's choice

The next best thing

Douglas Kamerow, US editor

dkamerow@bmj.com

The first 150 words of the full text of this article appear below.

Medicine and public health are always looking ahead. The problem is trying to figure out when something new is better and not just novel.

With an ageing population comes an increased incidence of macular degeneration, which can cause severe visual impairment. Usha Chakravarthy and Jennifer Lim discuss new, expensive drugs—growth factor inhibitors and monoclonal antibodies—that inhibit the development of macular degeneration. Their editorial (doi: 10.1136/bmj.39100.460671.BE) briefly reviews research that has established that these drugs are better than placebo in slowing neovascularization, but the drugs must be injected into the eye every month to be effective. How much is society willing to pay to keep our elderly population's vision intact?

Another promising technology riding to the rescue is computed tomography screening for the early detection of lung cancer. The authors of recently published cohort studies claim they have established that smokers benefit from CT scan screening. Pamela McMahon and David . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Preparing for the next flu pandemic
Wei Shen Lim, Anne Thomson, and Paul Little
BMJ 2007 334: 268-269. [Extract] [Full Text] [PDF]

New treatments for neovascular acute macular degeneration
Usha Chakravarthy and Jennifer I Lim
BMJ 2007 334: 269-270. [Extract] [Full Text] [PDF]

Computed tomography screening for lung cancer
Pamela M McMahon and David C Christiani
BMJ 2007 334: 271. [Extract] [Full Text] [PDF]

Role of combination antiviral therapy in pandemic influenza and stockpiling implications
Sotirios Tsiodras, John D Mooney, and Angelos Hatzakis
BMJ 2007 334: 293-294. [Extract] [Full Text] [PDF]

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
Clare L Gillies, Keith R Abrams, Paul C Lambert, Nicola J Cooper, Alex J Sutton, Ron T Hsu, and Kamlesh Khunti
BMJ 2007 334: 299. [Abstract] [Full Text] [PDF]




Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview